SYVA EMIT TOX SERUM TRICYCLIC ANTIDEPRESSANTS ASSAY 10445389

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2017-06-13 for SYVA EMIT TOX SERUM TRICYCLIC ANTIDEPRESSANTS ASSAY 10445389 manufactured by Siemens Healthcare Diagnostics Inc.

Event Text Entries

[77554004] Siemens healthcare diagnostics inc. (siemens) headquarters support center concluded that the cause of the discordant tricyclic antidepressant (tca) result on the urine survey sample was due to the operator running the tca as user defined method (udm). Based on the (b)(6) report provided by the operator, the use of methodology eia and 1000 ng/ml cutoff for this sample was graded as non-consensus. The syva emit tox serum tricyclic antidepressant assay was validated by siemens to be used with human or serum with a 300 ng/ml cutoff for serum. The operator is running this assay with urine patient samples, urine survey samples, and urine controls with a 1000ng/ml cutoff, which is a serum calibrator. According to the syva emit tox serum tricyclic antidepressants assay's instruction for use (ifu), "user defined modifications are not supported by siemens as they may affect performance of the system and assay results. It is the responsibility of the user to validate modifications to these instructions or use of the reagents on analyzers other than those included in siemens application sheets or these instructions for use". The user did not follow product instructions in the instruction for use, resulting in the cap failure and potential harm to the user or potential erroneous patient results. The instrument and the reagents used are performing according to specifications. No further evaluation of this device or reagent is required.
Patient Sequence No: 1, Text Type: N, H10


[77554005] An operator failed the (b)(6) survey with user defined method (udm) tricyclic anti-depressants (tca) on march 21, 2017. The operator reported that they selected the methodology as eia 1000 for cutoff for tricyclic group. The urine survey sample was spiked with 2000 ng/ml of doxepin and based on the syva emit tox serum tricyclic antidepressants assay's instruction for use (ifu), a concentration of 500 ng/ml of doxepin should show a positive response at the 300 ng/ml cutoff in serum or plasma sample. The operator obtained and reported a discordant negative result on this sample for tricyclic group. After obtaining the failure report, the operator re-ran calibration and controls and claimed that the calibration and controls recovered within acceptable ranges. The operator removed the same urine survey sample from the refrigerator and re-ran the survey sample. The operator obtained a negative result again. The operator is running this tca assay with urine samples, urine survey samples and urine controls with a 1000ng/ml cutoff, which is a serum calibrator. The operator claims that he has been reporting patient tca results to physician and they have not questioned the results. This survey failure did not cause a delay. The laboratory continued to run patient samples. There are no known reports of patient intervention or adverse health consequences. The operator has indicated that the issue is only related to discordant cap survey results.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2517506-2017-00532
MDR Report Key6637583
Date Received2017-06-13
Date of Report2017-06-13
Date of Event2017-05-20
Date Mfgr Received2017-05-22
Date Added to Maude2017-06-13
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactELIZABETH BERNASCONI
Manufacturer Street511 BENEDICT AVE
Manufacturer CityTARRYTOWN NY 10591
Manufacturer CountryUS
Manufacturer Postal10591
Manufacturer Phone9145242495
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS INC.
Manufacturer Street500 GBC DRIVE PO BOX 6101
Manufacturer CityNEWARK DE 197146101
Manufacturer CountryUS
Manufacturer Postal Code197146101
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameSYVA EMIT TOX SERUM TRICYCLIC ANTIDEPRESSANTS ASSAY
Generic NameSYVA EMIT TOX SERUM TRICYCLIC ANTIDEPRESSANTS ASSAY
Product CodeLFG
Date Received2017-06-13
Model NumberSYVA EMIT TOX SERUM TRICYCLIC ANTIDEPRESSANTS ASSA
Catalog Number10445389
Lot NumberK1
Device Expiration Date2019-09-09
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS INC
Manufacturer Address500 GBC DRIVE PO BOX 6101 NEWARK DE 197146101 US 197146101


Patients

Patient NumberTreatmentOutcomeDate
10 2017-06-13

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.